2.5 Systemic Disease Manifestations & Oral Cancer Risk Factors

2.5 Systemic Disease Manifestations & Oral Cancer Risk Factors

NBDHE Core Knowledge: The oral cavity frequently acts as an early indicator of underlying systemic disease. Dental hygienists must recognize oral manifestations of metabolic and autoimmune disorders, identify premalignant mucosal lesions, understand HPV- vs. tobacco-driven oral carcinogenesis, and master TNM cancer staging.

---

1. Systemic Diseases & Oral Manifestations

Diabetes Mellitus (Type 1 & Type 2)

Uncontrolled hyperglycemia ($HbA1c > 8.0%$) triggers a cascade of systemic and oral pathophysiological changes:

• Pathophysiology: Hyperglycemia leads to accumulation of Advanced Glycation End-products (AGEs) binding to their cell receptors (RAGE) on endothelial cells and macrophages. This interaction amplifies chronic inflammation, impairs neutrophil (PMN) chemotaxis and phagocytosis, impairs collagen synthesis, and damages microvasculature.
• Oral Manifestations: Severe, rapidly progressive periodontitis with pronounced attachment loss and alveolar bone resorption; multiple recurrent periodontal abscesses; delayed wound healing; severe xerostomia; burning mouth syndrome; enlarged parotid glands; and frequent opportunistic oral candidiasis.

Autoimmune Vesiculobullous & Dermatologic Disorders

• Oral Lichen Planus: A chronic autoimmune disease mediated by cytotoxic T-lymphocytes (CD8+) targeting basal cell layer keratinocytes, leading to basal cell degeneration (hydropic degeneration) and apoptosis (Civatte bodies).
  • Reticular Form: Most common form; asymptomatic white lace-like lines (Wickham striae) on bilateral buccal mucosa.
  • Erosive / Ulcerative Form: Painful shallow ulcers bounded by fine white striae and desquamative gingivitis. Clinical Note: Has a small risk of malignant transformation (~1–2%) into oral squamous cell carcinoma; requires regular monitoring.
• Pemphigus Vulgaris: A severe, potentially fatal autoimmune disease caused by autoantibodies (IgG) directed against desmoglein-3, a desmosomal cell adhesion glycoprotein.
  • Histology: Intraepithelial acantholysis (loss of intercellular connections between keratinocytes) resulting in suprabasal clefting. Tzanck cells (rounded, detached acantholytic cells) present on cytology smear.
  • Clinical Signs: Fragile bullae that rupture quickly leaving painful, raw mucosal erosions. Demonstrates a positive Nikolsky sign (slight mechanical pressure or rubbing of unimpaired mucosa causes sloughing or blister formation).
• Mucous Membrane Pemphigoid (Cicatricial Pemphigoid): An autoimmune disease caused by autoantibodies directed against hemidesmosomal proteins (BP180, laminin 332) in the basement membrane zone.
  • Histology: Subepithelial clefting separating the entire epithelium from the underlying lamina propria.
  • Clinical Signs: Tougher bullae; persistent desquamative gingivitis; negative or infrequent Nikolsky sign. Can cause scarring (cicatrization) of conjunctival mucosa leading to blindness.

Gastrointestinal & Hematologic Manifestations

• Crohn Disease: Chronic inflammatory bowel disease causing non-caseating granulomatous inflammation. Oral signs include linear, deep mucosal ulcers with hyperplastic margins; persistent lip swelling (cheilitis granulomatosa); and a characteristic "cobblestone" appearance of the buccal mucosa.
• Gastroesophageal Reflux Disease (GERD) & Bulimia Nervosa: Severe intrinsic acid exposure (stomach acid, pH ~1.5–2.0) causes perimolysis—the chemical erosion of tooth enamel. Typically affects the lingual surfaces of maxillary anterior teeth, creating smooth, glossy enamel surfaces with raised amalgam restorations ("standing proud").
• Iron Deficiency Anemia: Causes loss of filiform papillae resulting in a smooth, red, painful depapillated glossitis, angular cheilitis, and mucosal pallor. In Plummer-Vinson Syndrome, iron deficiency anemia is accompanied by esophageal webs and dysphagia, conferring an increased risk of oral and pharyngeal carcinoma.
• Pernicious Anemia: Vitamin $B_{12}$ deficiency secondary to lack of intrinsic factor production by gastric parietal cells. Presents with Hunter glossitis—a fiery red, painful, beefy tongue with complete papilla atrophy.
• Leukemia: Malignant proliferation of white blood cells. Frequently presents initially in the dental office with spontaneous gingival bleeding, petechiae, mucosal pallor, opportunistic infections, and severe leukemic gingival infiltrates (bogginess and massive hyperplastic enlargement of attached gingiva).

---

2. Premalignant Mucosal Lesions

Premalignant (potentially malignant) oral lesions exhibit an elevated risk of developing invasive squamous cell carcinoma:

• Leukoplakia: A white patch or plaque that cannot be scraped off and cannot be characterized clinically or pathologically as any other specific disease. Diagnosis of exclusion. Histopathologically varies from hyperkeratosis to varying grades of epithelial dysplasia (mild, moderate, severe) or invasive carcinoma. Malignancy transformation rate is 5–25%. High-risk sites: floor of mouth, ventral/lateral tongue, soft palate.
• Erythroplakia: A smooth, velvety red patch that cannot be clinically or pathologically diagnosed as any other condition. High-Yield Board Fact: Erythroplakia is significantly more dangerous than leukoplakia; over 90% of erythroplakic lesions exhibit severe epithelial dysplasia, carcinoma in situ, or invasive squamous cell carcinoma upon biopsy.
• Proliferative Verrucous Leukoplakia (PVL): A progressive, recalcitrant form of leukoplakia characterized by multifocal verrucous white plaques. Highly resistant to therapy with an extremely high rate of transformation to verrucous carcinoma or squamous cell carcinoma. Often unrelated to tobacco use.

---

3. Oral & Oropharyngeal Carcinoma: Risk Factors & HPV Etiology

Squamous Cell Carcinoma (SCC) represents over 90% of all primary malignancies of the oral cavity and oropharynx.

Classic Oral Squamous Cell Carcinoma (OSCC)

• Primary Risk Factors: Heavy tobacco use (cigarettes, cigars, pipes, smokeless tobacco) and heavy alcohol consumption.
• Synergistic Effect: Tobacco combustion carcinogens (polycyclic aromatic hydrocarbons, nitrosamines) and alcohol act synergistically. Alcohol acts as a solvent, increasing mucosal permeability to tobacco carcinogens while its metabolite (acetaldehyde) directly damages cellular DNA. Combined heavy use increases oral cancer risk up to 30 to 150 times compared to non-users.
• High-Risk Oral Sites: Lateral and ventral borders of the tongue, floor of the mouth, and soft palate / complex retromolar pad region.

HPV-Associated Oropharyngeal Squamous Cell Carcinoma (OPC)

• Etiology: High-risk Human Papillomavirus Type 16 (HPV-16) (and to a lesser extent HPV-18) is the primary driver of the dramatic rise in oropharyngeal cancers (tonsils, base of tongue, soft palate).
• Molecular Mechanism: Viral double-stranded DNA integrates into host keratinocyte genomes, expressing two key viral oncogenes:
  1. E6 Oncogene: Binds to and promotes ubiquitin-mediated degradation of the p53 tumor suppressor protein, preventing cell apoptosis.
  2. E7 Oncogene: Binds to and inactivates the Retinoblastoma (pRb) protein, causing uncontrolled cell cycle progression past the G1/S checkpoint.
• Patient Profile: Typically younger adults (ages 40–60), male, with minimal or no history of tobacco or alcohol use.
• Diagnostic Biomarker: Strong expression of p16 protein detected via immunohistochemistry.
• Prognosis: HPV-positive oropharyngeal carcinomas exhibit a significantly better prognosis, higher treatment responsiveness to radiation/chemotherapy, and higher 5-year survival rates compared to tobacco-induced cancers.

---

4. TNM Cancer Staging System

The American Joint Committee on Cancer (AJCC) utilizes the TNM staging system to categorize oral and oropharyngeal carcinomas:

• T (Primary Tumor Size):
  • $T_x$: Primary tumor cannot be assessed.
  • $T_0$: No evidence of primary tumor.
  • $T_{is}$: Carcinoma in situ (confined to epithelium).
  • $T_1$: Tumor diameter $\le 2\text{ cm}$.
  • $T_2$: Tumor diameter $> 2\text{ cm}$ but $\le 4\text{ cm}$.
  • $T_3$: Tumor diameter $> 4\text{ cm}$.
  • $T_4$: Advanced local invasion into adjacent structures (deep extrinsic muscle of tongue, cortical bone, maxilla, skin).
• N (Regional Lymph Node Involvement):
  • $N_0$: No regional lymph node metastasis.
  • $N_1$: Metastasis in a single ipsilateral lymph node $\le 3\text{ cm}$.
  • $N_2$: Metastasis in a single ipsilateral node $> 3\text{ cm}$ but $\le 6\text{ cm}$, or multiple ipsilateral/bilateral nodes $\le 6\text{ cm}$.
  • $N_3$: Metastasis in a lymph node $> 6\text{ cm}$.
• M (Distant Metastasis):
  • $M_0$: No distant metastasis.
  • $M_1$: Distant metastasis present (most commonly lungs, liver, bone).